Sep 2026
Abstract B074: Comparative analysis of next-generation KRAS inhibitors in patient derived pancreatic cancer organoids
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers with a five-year survival rate below 10%. Due to aggressiveness and lack of early detection methods, patients are often diagnosed at an advanced stage, leaving few therapeutic options. This emphasizes the need for a deeper understanding of the mo...
Paul G. Winckler, Georg Vladimirov, Lennart Herrlich et al.
· Cancer Research · 0 citations